Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd Edition)

$900.00$1,800.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Report Overview

A biosimilars boom is expected and both biopharma and contract manufacturers want to be positioned to capture a piece of the market. ISR’s Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition) goes into depth on one of the most important aspects of biosimilars: manufacturing. Manufacturing these complex products in a cost-efficient manner will be a critical component to successfully commercializing biosimilars and the anticipated boom. Outsourced manufacturing decision-makers share their perspectives on selling and manufacturing biosimilars, how much biosimilar manufacturing is expected to be outsourced, comfort levels in outsourcing to particular CMOs, and the key challenges associated with the manufacture of biosimilars.

 

What you will learn:

  1. Understand the motivations for selling and/or manufacturing biosimilars and biobetters
  2. Primary drivers for outsourcing biosimilar manufacturing and perceived challenges in biosimilar manufacturing
  3. Get an early indication of market leaders by knowing which contract manufacturers respondents would be most compfortable using for biosimilar production

 

Methodology:

  • Identify peer-trusted CMOs to shortlist for outsourced biosimilar manufacturing projects
  • Understand where, geographically, biopharmaceutical companies are looking to manufacture biosimilars
  • Gain insight into the characteristics sponsors value from a CMO and leverage these attributes in sales and marketing efforts
  • For Biopharma: Understand and assess perceived challenges to biosimilar manufacturing to make an informed decision on whether to enter the market. For biopharmas already in the market, make a more educated CMO selection for an outsourced biosimilar project.
  • For CMO: Start to understand the market potential for for outsourced biosimilars manufacturing with respect to CMO selection attributes, desired bioprocessing equipment, and preferred manufacturing geographies.

 

Report Contents:

  1. Methodology
  2. Respondent Qualifications
  3. Prologue
  4. Study Data
  5. Demographics

Questions?

Our team is here to help.

For questions about syndicated report purchases, custom research solutions, or other billing-related topics, please contact sales@ISRreports.com.